Series of Clinical and Medical Case Reports and Reviews

Archive | JSCMCRR

Case Report

An Alternative Treatment of Diabetes with Ganoderma lucidum: A Case Report

Islam KA, Hossain M, Choudhury BK, Alam N, Joy SI and Hossain S*

An Alternative Treatment of Diabetes with Ganoderma lucidum: A Case Report Read More »

Abstract Full TextPDF Cite
Islam KA, Hossain M, Choudhury BK, et al. An alternative treatment of diabetes with Ganoderma lucidum: a case report. Series Clin Med Case Rep Rev. 2024;2(1):1-7.
Ganoderma lucidum (L) is considered an effective medicinal mushroom. The main goal of this research was to investigate whether the beneficial effects of G. lucidum found in various in vitro or animal studies can be translated to chronic metabolic diseases such as diabetes in humans. Here, we present a case study of a person with diabetes after treatment with G. lucidum and provide important information on fasting blood glucose (FG) levels, glycated hemoglobin (HbA1c), lipid profile, and various other blood parameters. After taking G. lucidum hot water extract for three months, FG levels decreased from 198 mg/dL to 177.3 mg/dL. HbA1c fell by 1.5%. Serum total cholesterol (TC) decreased from 210 to 170 mg/dL, and triglyceride (TG) levels decreased from 220 to 150 mg/dL, while serum high-density cholesterol (HDL-C) increased from 25 to 35 mg/dL. Low-density cholesterol (LDL-C) only decreased by 9 mg/dL. Serum creatinine, alkaline phosphatase (ALP), alanine aminotransferase (ALT), and total bilirubin levels were not changed. Therefore, it is concluded that G. lucidum hot water extract had antidiabetic and antidyslipidemic effects without affecting hepatorenal functions.
Article DOI: 10.54178/2993-3579.v2i1a2027
Research Article

Efficacy of Different Treatment Approaches (Insulin and Metformin) in Women with Gestational Diabetes Mellitus (GDM)

Asatiani N*, Kurashvili R and Shelestova E

Efficacy of Different Treatment Approaches (Insulin and Metformin) in Women with Gestational Diabetes Mellitus (GDM) Read More »

Abstract Full TextPDF Cite
Asatiani N, Kurashvili R, Shelestova E. Efficacy of different treatment approaches (insulin and metformin) in women with gestational diabetes mellitus (GDM). Series Clin Med Case Rep Rev. 2024;2(1):1-8.
Background and Purpose: The pharmacotherapy options in patients with gestational diabetes mellitus (GDM) are insulin or oral antihyperglycemic agents. Insulin is the preferred medication for treating hyperglycemia, but in recent years, metformin has been increasingly used in the treatment of GDM. Aim: The aim is to assess the efficacy of different treatments (insulin and metformin) in women with GDM. Methods: Screening for GDM was performed in 2422 pregnant women and revealed GDM in 119 women [75 g oral glucose tolerance test (OGTT) was performed at 24–28 weeks of gestation]. All patients started treatment at 24–29 weeks of gestation. The patients were divided into two groups (Gr.): Gr. 1 had 68 patients treated with diet and insulin therapy. Gr. 2 had 51 patients treated with diet and metformin. Results: In the 2nd trimester, HbA1c (%) levels for Gr. 1 and Gr. 2 were 6.7 (0.05) and 6.4 (0.6), respectively. By term, HbA1c levels statistically decreased in both groups, but we did not find a statistical difference between the groups. Women from Gr. 2 gained less weight compared to Gr. 1 (1.89 ± 3.88 vs. 4.53 ± 3.67 kg; P = 0.003). In Gr. 1, the percentage of preeclampsia was 2.9%, and in Gr. 2, 3.9% (P = 0.7773, OR - 1.33). We did not find a statistical difference between the groups. The incidence of preterm delivery before 37 weeks of gestation in Gr. 1 was lower than in Gr. 2 (P = 0.7311, OR - 1.33), and we also did not find a statistical difference between the groups. Perinatal mortality was observed in Gr. 1 - 1.4% and in Gr. 2 - 1.9% (P = 0.8402, OR - 1.33). In both groups, we observed a high percentage of cesarean section (Gr. 1 - 32.3% and Gr. 2 - 29.4% (P = 0.7651, OR -1.0909), but we did not find a statistical difference between the groups. In both groups, the percentage of macrosomia was high, despite good glycemic control maintained through pregnancies: 20.0% and 23.0% for Gr. 1 and Gr. 2, respectively (P = 0.9236, OR - 1.0256), and again no statistical difference was found between the groups. Percent of neonatal hypoglycemia was lower in Gr. 2 (1.9%) than in Gr. 1 (4.41%) (P = 0.9236, OR – 1.0256). Percent of respiratory distress syndrome was 2.94% and 3.92% for Gr. 1 and Gr. 2, respectively (P = 0.9694, OR - 0.9893), with no statistical difference between the groups. Conclusion: We did not find differences between patients treated with diet and insulin therapy and patients treated with diet and metformin. The percentage of preeclampsia, preterm delivery, macrosomia, and perinatal death were similar in both groups; only maternal weight gain was lower in the metformin group.
Article DOI: 10.54178/2993-3579.v2i1a2026
Case Report

Tuberous Sclerosis Complex (TSC) Identified by Genetic Testing After Histologic Diagnosis of Chromophobe Renal Cell Carcinoma

Fernandez A*, Pautler SE, Cordero M, Avila-Monteverde E, Chipollini J, Cifuentes ME, Cifuentes LAE and Lee BR

Tuberous Sclerosis Complex (TSC) Identified by Genetic Testing After Histologic Diagnosis of Chromophobe Renal Cell Carcinoma Read More »

Abstract Full TextPDF Cite
Fernandez A, Pautler SE, Cordero M, et al. Tuberous sclerosis complex (TSC) identified by genetic testing after histologic diagnosis of chromophobe renal cell carcinoma. Series Clin Med Case Rep Rev. 2024;2(1):1-3.
We report the case of a female patient with a histologic diagnosis of chromophobe renal cell carcinoma (ChRCC) after a left laparoscopic radical nephrectomy. Due to the unusual histologic diagnosis, a genetic test was ordered identifying tuberous sclerosis disease.
Article DOI: 10.54178/2993-3579.v2i1a2025
Systematic Review

Quality of Life, Fatigue and Social Support Among Healthcare Professionals During the COVID 19 Pandemic: A Systematic Review

Theofilou P* and Moschopoulos A

Quality of Life, Fatigue and Social Support Among Healthcare Professionals During the COVID 19 Pandemic: A Systematic Review Read More »

Abstract Full TextPDF Cite
Theofilou P, Moschopoulos A. Quality of life, fatigue and social support among healthcare professionals during the COVID-19 pandemic: a systematic review. Series Clin Med Case Rep Rev. 2023;1(6):1-11.
Background: With the demanding nature of their work, healthcare professionals often face challenges that can affect their overall well-being. Understanding the factors that affect their quality of life is crucial to developing effective interventions and support systems. Aim: The present systematic review investigated the relationship between quality of life, fatigue, and social support among healthcare professionals during the COVID-19 pandemic. Methods: The search for studies included in the study was performed using four online databases: PubMed, Embase, Scopus, and Web of Science. The search was limited to articles published in English between January 1, 2020 and March 31, 2023. In total, 14 articles were included in the systematic review. Results: The findings of this work showed a negative correlation between fatigue and quality of life in health professionals, as well as a positive correlation between social support and quality of life. Furthermore, it was found that the increased social support of healthcare professionals during the period of COVID-19 is associated with a better quality of professional life. Conclusion: It seems that higher levels of social support are associated with lower levels of anxiety and depression among health professionals.
Article DOI: 10.54178/2993-3579.v1i6a2023
Case Report

Anaesthesia for Fixation of Pathological Fractures in a Patient with Multiple Myeloma with Comorbidities

Akanksha*, Govil V, Yadav D, Kumar TH, Kumar S and Singh A

Anaesthesia for Fixation of Pathological Fractures in a Patient with Multiple Myeloma with Comorbidities Read More »

Abstract Full TextPDF Cite
Akanksha, Govil V, Yadav D, et al. Anaesthesia for fixation of pathological fractures in a patient with multiple myeloma with comorbidities. Series Clin Med Case Rep Rev. 2023;1(6):1-5.
Introduction: Patients with multiple myeloma (MM) have improved life expectancy and quality of life in the last decade with the introduction of new chemotherapeutic agents and improvement in treatment modalities. Due to this, patients are now being treated for surgical implications of the disease, which was not possible earlier. Case Report: We report a case of a 42-year male with MM with fractured femur bone posted for fixation of pathological fracture femur, discussing the perioperative considerations and management for anaesthesiologists. Conclusion: Proper anaesthetic management is crucial for the successful fixation of pathological fractures in patients with MM and comorbidities, considering the unique challenges posed by the disease and its associated complications.
Article DOI: 10.54178/2993-3579.v1i6a2022
Research Article

Time Factor Hypothesis: Towards Identifying Onset of Alzheimer’s Disease in Younger Adults

Anyaiwe OED*, Gwarzo Z and Konwe CS

Time Factor Hypothesis: Towards Identifying Onset of Alzheimer’s Disease in Younger Adults Read More »

Abstract Full TextPDF Cite
Anyaiwe OED, Gwarzo Z, Konwe CS. Time factor hypothesis: towards identifying onset of Alzheimer’s disease in younger adults. Series Clin Med Case Rep Rev. 2023;1(6):1-8.
Supplementary File
Introduction: Several hypotheses explain the onset and pathology of Alzheimer’s disease (AD), such as the amyloid hypothesis and the tau hypothesis. Consequently, various biomarkers have been identified and drugs developed, but the fight against the AD epidemic is still ongoing. Perhaps it is time to explore new hypotheses. To begin with, researchers have shown that neuropathology associated with AD typically starts to develop decades before the clinical onset or manifestation of the disease. However, therapeutic interventions are still being designed to address mild-to-moderate stages of the disease, which are unfortunately irreversible. Methods: We have reviewed various mathematical models to identify any missing parameters that could support the proposed time factor hypothesis for AD. In addition, we have developed a cognitive function algorithm that utilizes the identified parameters. The algorithm’s results are used to predict the likelihood of neuritic dystrophy. Results: With mathematical evidence, we emphasize the importance of timely diagnosis of AD and provide support for considering an earlier age of 30 years (rather than 60 years or older) for effective interventions, including diagnosis and drug development. Discussion: Among other points, we showed that 42 aggregation starts around age 30–40 years. With this information, we propose the need to re-engineer the concepts behind the science of AD. The number of AD patients will experience a nose dive if effort aimed at timely prevention of (for instance) 42 aggregation is expended.
Article DOI: 10.54178/2993-3579.v1i6a2019
Case Report

Atypical Presentation of Ramsay Hunt Syndrome: A Case Report

Daoud MHS, Elamin AEA*, Ahmed A, Mohmed MHA and Hamid MH

Atypical Presentation of Ramsay Hunt Syndrome: A Case Report Read More »

Abstract Full TextPDF Cite
Daoud MHS, Elamin AEA, Ahmed A, et al. Atypical presentation of Ramsay Hunt syndrome: a case report. Series Clin Med Case Rep Rev. 2023;1(6):1-4.
Background: This case emphasizes the atypical presentation of Ramsay Hunt syndrome (RHS), in which the rash was distributed over cervical dermatomes (C3, C4). Case Presentation: A 55-year-old Sudanese woman presented with left-side mouth deviation and difficulty in the closure of her right eye which happened two weeks after the appearance of a vesicular rash over the right side of her head, ear, down to the right side of her neck as well as submandibular area, and improved with treatment (acyclovir and prednisolone). Conclusion: Physicians should be aware of typical and atypical presentations of RHS to facilitate prompt diagnosis and provide appropriate management. Early intervention with antiviral and corticosteroids has been shown to significantly improve outcomes in these patients.
Article DOI: 10.54178/2993-3579.v1i6a2018
Scroll to Top